BSE See NSE See 45,079.55
446.90 (1%)

Is It The Right Time To Invest Lump Sum?


The year 2018 happens to be quite eventful for the equity markets. There were lot of events that led to the heightened volatility in the equity markets. It all started with the reintroduction of long term capital gains (LTCG) tax, then came the rise and fall of crude oil prices, and most recently, the results of elections in five states and, finally, the resignation of Urjit Patel as the governor of the Reserve Bank of India. The worst impacted stocks due to these events were the mid-caps and small-caps, which saw a sharp cut in their prices.

To read the entire article, you must be a DSIJ magazine subscriber.

Comments are only visible to subscribers.

DSIJ Mindshare

Airtel jumps almost 3 per cent after TRAI reports of adding more subscribers than Jio in September

Anthony Fernandes / Article rating: 5.0

The shares of Bharti Airtel were trading in the green on Friday after Telecom Regulatory Authority of India (TRAI) in its subscription data report revealed that for the month of September 2020, Airtel reigned supreme with more than 3.77 million subscriber addition, followed by Reliance Jio, which managed to add 1.46 million new subscribers in comparison.

Zydus gets nod for conducting phase III clinical trials of its much-awaited COVID vaccine

abhinav lahoti / Article rating: 5.0

Zydus Cadila today announced that it has received permission to start the phase III clinical trials in the COVID-19 patients with its biological therapy, Pegylated Interferon alpha-2b, ‘PegiHepTM’ from Drugs Controller General of India (DCGI).  The trials will be conducted on 250 patients across 20-25 centres in India, starting in December.